CRF type 1 receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors.
The dorsal periaqueductal gray (dPAG) is involved in defensive coping reactions to threatening stimuli. Corticotropin releasing factor (CRF) is substantially implicated as a direct modulator of physiological, endocrine and behavioral responses to a stressor. Previous findings demonstrate a direct role of the central CRF system in dPAG-mediated defensive reactions toward a threatening stimulus. These include anxiogenic behaviors in the elevated plus maze (EPM) in rats and defensive reactions in both the mouse defense test battery (MDTB) and rat exposure test (RET) paradigms in mice. Furthermore, CRF was shown to directly and dose-dependently excite PAG neurons in vitro. The aim of the present series of experiments was to directly evaluate the role of the CRF1 receptor (CRF1) in dPAG-induced defensive behaviors in the MDTB and the RET paradigms. For this purpose, cortagine, a novel CRF1-selective agonist, was directly infused into the dPAG. In the RET the high dose of cortagine (100 ng) significantly affected spatial avoidance measures and robustly increased burying behavior, an established avoidance activity, while having no effects on behaviors in the MDTB. Collectively, these results implicate CRF1 in the dPAG as a mediator of temporally and spatially dependent avoidance in response to controllable and constant stimuli.
Litvin
Yoav
Y
Department of Psychology, University of Hawaii at Manoa, 2430 Campus Rd., Honolulu, HI 96822, USA. litvin@hawaii.edu
Pentkowski
Nathan S
NS
Blanchard
D Caroline
DC
Blanchard
Robert J
RJ
D000818:Animals; D001007:Anxiety / Q000378:metabolism / Q000503:physiopathology*; D001522:Behavior, Animal / Q000502:physiology*; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage; D003674:Defense Mechanisms; D008297:Male; D051379:Mice; D008959:Models, Neurological; D010487:Periaqueductal Gray / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D018019:Receptors, Corticotropin-Releasing Hormone / Q000378:metabolism* / Q000502:physiology*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage; D000099052:CRF Receptor, Type 1
D018019:Receptors, Corticotropin-Releasing Hormone; D011993:Recombinant Fusion Proteins; C488590:cortagine; D000099052:CRF Receptor, Type 1; D003346:Corticotropin-Releasing Hormone